FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

385564000: Drotrecogin alfa (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2003. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1459743014 Drotrecogin alfa (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
1479769016 Drotrecogin alfa en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Drotrecogin alfa Is a Recombinant human activated protein c true Inferred relationship Existential restriction modifier
Drotrecogin alfa Has disposition Coagulation factor inhibitor false Inferred relationship Existential restriction modifier
Drotrecogin alfa Has disposition Protease inhibitor protein true Inferred relationship Existential restriction modifier
Drotrecogin alfa Has disposition Activated coagulation factor true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing drotrecogin alfa Has active ingredient True Drotrecogin alfa Inferred relationship Existential restriction modifier 1
Product containing precisely drotrecogin alfa 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has active ingredient False Drotrecogin alfa Inferred relationship Existential restriction modifier
Drotrecogin alfa 20mg powder for infusion solution vial Has active ingredient False Drotrecogin alfa Inferred relationship Existential restriction modifier
Product containing precisely drotrecogin alfa 20 milligram/1 vial powder for conventional release solution for injection Has basis of strength substance True Drotrecogin alfa Inferred relationship Existential restriction modifier 1
Product containing precisely drotrecogin alfa 20 milligram/1 vial powder for conventional release solution for injection Has precise active ingredient True Drotrecogin alfa Inferred relationship Existential restriction modifier 1
Product containing drotrecogin alfa in parenteral dose form (medicinal product form) Has active ingredient True Drotrecogin alfa Inferred relationship Existential restriction modifier 1
Drotrecogin alfa Has active ingredient True Drotrecogin alfa Inferred relationship Existential restriction modifier 1
Product containing only drotrecogin alfa in parenteral dose form (medicinal product form) Has active ingredient True Drotrecogin alfa Inferred relationship Existential restriction modifier 1
Product containing precisely drotrecogin alfa 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance True Drotrecogin alfa Inferred relationship Existential restriction modifier 1
Product containing precisely drotrecogin alfa 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Drotrecogin alfa Inferred relationship Existential restriction modifier 1
Product containing precisely drotrecogin alfa 20 milligram/1 vial powder for conventional release solution for injection Has active ingredient False Drotrecogin alfa Inferred relationship Existential restriction modifier
Drotrecogin alfa 5mg powder for solution for injection vials Has active ingredient False Drotrecogin alfa Inferred relationship Existential restriction modifier
Drotrecogin alfa 5mg powder for solution for injection vials Has active ingredient False Drotrecogin alfa Inferred relationship Existential restriction modifier
Product containing precisely drotrecogin alfa 20 milligram/1 vial powder for conventional release solution for injection Has active ingredient False Drotrecogin alfa Inferred relationship Existential restriction modifier
Xigris 5mg powder for solution for injection vials (Eli Lilly & Co Ltd) Has active ingredient False Drotrecogin alfa Inferred relationship Existential restriction modifier
Xigris 20mg powder for solution for injection vials (Eli Lilly & Co Ltd) Has active ingredient False Drotrecogin alfa Inferred relationship Existential restriction modifier
Drotrecogin alfa 5mg powder for solution for injection vials 1 vial Has active ingredient False Drotrecogin alfa Inferred relationship Existential restriction modifier
Drotrecogin alfa 20mg powder for solution for injection vials 1 vial Has active ingredient False Drotrecogin alfa Inferred relationship Existential restriction modifier
Xigris 5mg powder for solution for injection vials (Eli Lilly & Co Ltd) 1 vial Has active ingredient False Drotrecogin alfa Inferred relationship Existential restriction modifier
Xigris 20mg powder for solution for injection vials (Eli Lilly & Co Ltd) 1 vial Has active ingredient False Drotrecogin alfa Inferred relationship Existential restriction modifier
Xigris 5mg powder for solution for injection vials (Eli Lilly & Co Ltd) Has specific active ingredient True Drotrecogin alfa Inferred relationship Existential restriction modifier
Drotrecogin alfa 5mg powder for solution for injection vials Has specific active ingredient True Drotrecogin alfa Inferred relationship Existential restriction modifier
Xigris 5mg powder for solution for injection vials (Eli Lilly & Co Ltd) 1 vial Has specific active ingredient True Drotrecogin alfa Inferred relationship Existential restriction modifier
Drotrecogin alfa 5mg powder for solution for injection vials 1 vial Has specific active ingredient True Drotrecogin alfa Inferred relationship Existential restriction modifier
Xigris 20mg powder for solution for injection vials (Eli Lilly & Co Ltd) 1 vial Has specific active ingredient True Drotrecogin alfa Inferred relationship Existential restriction modifier
Drotrecogin alfa 20mg powder for solution for injection vials 1 vial Has specific active ingredient True Drotrecogin alfa Inferred relationship Existential restriction modifier
Product containing precisely drotrecogin alfa 20 milligram/1 vial powder for conventional release solution for injection Has specific active ingredient True Drotrecogin alfa Inferred relationship Existential restriction modifier
Xigris 20mg powder for solution for injection vials (Eli Lilly & Co Ltd) Has specific active ingredient True Drotrecogin alfa Inferred relationship Existential restriction modifier
Drotrecogin alfa Has active ingredient False Drotrecogin alfa Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start